Heparin-binding epidermal growth factor-like growth factor and hepatocyte growth factor inhibit cholestatic liver injury in mice through different mechanisms

In contrast to hepatocyte growth factor (HGF), the therapeutic potential and pathophysiologic roles of heparin-binding epidermal growth factor-like growth factor (HB-EGF) in liver diseases remain relatively unknown. To address the lack of effective pharmacologic treatments for cholestatic liver inju...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakamoto, Kouichi, Khai, Ngin Cin, Wang, Yuqing, Irie, Rie, Takamatsu, Hideo, Matsufuji, Hiroshi, Kosai, Ken-Ichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5117744/
https://www.ncbi.nlm.nih.gov/pubmed/27779646
http://dx.doi.org/10.3892/ijmm.2016.2784

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5117744/
https://www.ncbi.nlm.nih.gov/pubmed/27779646
http://dx.doi.org/10.3892/ijmm.2016.2784

Ejemplares similares